Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

EU Joint Clinical Assessment (JCA) in Rare Disease

EU Joint Clinical Assessment is no longer theoretical. The HTA Coordination Group’s 2025 Annual Report marks the[…]

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept